Navigation Links
B. Braun and CME America Partner to Provide BodyGuard® Infusion Pumps
Date:7/18/2011

BETHLEHEM, Pa., July 18, 2011 /PRNewswire/ -- In an effort to expand its offerings for infusion therapy in both the acute care hospital and outpatient markets, with an initial focus on home infusion, B. Braun Medical Inc. (B. Braun) announced today an exclusive alliance with CME America to distribute the BodyGuard® line of electronic infusion pumps.

(Logo: http://photos.prnewswire.com/prnh/20081022/NYW008LOGO)

The five-year exclusive distribution agreement allows B. Braun customers access to the safety, reliability and therapeutic flexibility of CME America's BodyGuard electronic infusion pumps.

"B. Braun's collaboration and synergy with CME America further demonstrates our commitment to bringing our customers infusion therapy systems that address key home infusion therapy needs, such as flexibility and a wide-range of programming options, while remaining cost-effective," said Eric Melanson, Director of Marketing for Infusion Systems, B. Braun Medical Inc. "Strong hallmarks of the BodyGuard product portfolio include wide capabilities in therapy settings, a host of green power options, and an on-pump history capability."

B. Braun's customers will have access to the full line of BodyGuard electronic infusion pumps, including these four pump models:

  • BodyGuard 323 multi-therapy pump – Programmable in five modes (continuous, intermittent, TPN, PCA and 25-Step) to deliver antibiotics, chemotherapy, parenteral and enteral nutrition fluids, analgesics and patient-controlled analgesia (PCA). Flexible configuration allows for pole-mounted use and a carrying pouch for homecare.
  • BodyGuard 545 epidural pump – Specially designed and color-coded for epidural medication infusion.
  • BodyGuard 575 PCA pump – Delivers continuous, bolus and clinician-activated bolus infusions for patient-controlled analgesia (PCA).
  • BodyGuard 121 (Twins) pump – A two-channel pump designed for hospital and home use when administering more than one medication.

About CME America

CME America, LLC is a U.S. Food and Drug Administration (FDA)-registered medical device manufacturer and specification developer based in Golden, Colorado. CME infusion pumps and syringe systems have been used in hospitals, clinics and patients' homes in the United States and Canada for more than 10 years. Since 1993, CME infusion products, including electronic infusion pumps, syringe infusion pumps and disposable infusion sets, have become well-established in Europe and Asia for their functional designs and reliable performance.

Worldwide, more than 75,000 CME infusion pumps have been sold to customers in 46 countries. CME pumps are used for a variety of IV therapy applications in such settings as hospitals, surgery centers, homecare and research centers. CME pumps are known for their simplicity of use, clinical flexibility, accuracy and innovative programming and safety features derived from direct user input.

About B. Braun

B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company's "Sharing Expertise®" philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, e-mail us at inquiry.us@bbraun.com or visit B. Braun at www.bbraunusa.com.    


'/>"/>
SOURCE B. Braun
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. B. Braun Renal Therapies Division Announces Availability of Advanced Apheresis Therapy System
2. B. Braun Acquires Patent for Enhanced Wireless Communication Between Medical Devices and Hospital Information Management Systems
3. HASCO Medical Announces Mobility Freedom Has Been Named the Authorized Braun Vehicle Dealership
4. B. Braun Medical Inc. Named Best Company to Work For
5. B. Braun Obtains Permanent Injunction
6. B. Braun Offers Wound Patients a New Over-the-Counter Wound Management Gel - Prontosan®
7. B. Braun Voluntarily Recalls Seven Lots of Heparin Manufactured in 2008 Due to Supplier-Initiated Recall of Heparin Active Pharmaceutical Ingredient (API)
8. B. Braun Wins Third Consecutive Safety IV Catheters Contract Award from Premier, Inc.
9. FDA-Approved Cefepime Now Available for Use in B. Brauns DUPLEX® System
10. B. Braun Customers Gain Premier Access to Zynx Health Device Networks Evidence-based, Customizable Drug Library Program
11. B. Braun Large Volume Heparin Infusion Solutions Now Available
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)...  International Biophysics Corporation, a global medical device manufacturer based ... 34% revenue growth in 2016 when compared to the previous ... growth was fueled by its AffloVest® sales in ... of its global sales of surgical product lines. ... enter our 25 th year in delivering high-quality, innovative ...
(Date:2/27/2017)... , Feb. 27, 2017  RegeneRx Biopharmaceuticals, ... clinical-stage drug development company focused on tissue protection, ... for RGN-137, GtreeBNT Co., Ltd., received a positive ... 3 clinical trial design for RGN-137 to treat ... healing gel that incorporates Thymosin beta 4 ("Tß4") ...
(Date:2/27/2017)... Leading Countries, Technologies and Companies The global ... CAGR of 8.9% from 2016-2021 and CAGR of 9.2% from 2021-2027. ... from 2016 to 2027. The market is estimated at $816m in ... ... to discover how you can exploit the future business opportunities emerging ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... ... last week. In addition, Discount Power's RCE (Residential Customer Equivalent) count exceeds ... 2014. The company had 800 customers and 2,250 RCEs at the time of ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of Kim ... over nerve agents and the deadly use of chemical weapons. Many questions exist about ... even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical ...
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing a new ... B2B Sellers will now only pay for B.A.N.T. quality sales leads based on the ... said, “Given the new reality that B2B buyers are controlling the sales process via ...
(Date:2/25/2017)... Viejo, CA (PRWEB) , ... February 25, 2017 , ... ... with ProSharpen Color tools from Pixel Film Studios. With ProSharpen Color users have total ... sliders to easily refine their color range. With color spectrum tools users can visually ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of genetic variants implicated ... to eight genes that may explain why susceptibility to one of the disorders could ... study published today in the journal npj Schizophrenia. , “There is a wealth ...
Breaking Medicine News(10 mins):